Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. J. Erpenbeck, A. M. Salapatek, P. Patel, D. Carew, G. Dubois, S. Perry, M. Larbig (Basel, Switzerland; Toronto, Canada; Horsham, West Sussex, United Kingdom). QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber. Eur Respir J 2014; 44: Suppl. 58, 4069

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of 10 day treatment with the CRTh2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Comorbidity of allergic rhinitis and asthma to birch allergen in an environmental exposure chamber Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Should patients with mild asthma be excluded from allergic rhinitis drug trials? Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens Source: International Congress 2015 – Asthma and lung immunology Year: 2015 The impact of psychological distress on allergic rhinitis and asthma control Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Intranasal GSK2245035 induces prolonged reductions in nasal responsiveness to allergen Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Clinical characteristics of seasonal rhinitis and co-existence with asthma Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Predictors factors for asthma in patients with rhinitis Source: International Congress 2014 – Clinical allergy Year: 2014 Distribution of mast cells and their interactions with nerve in allergic rhinitis Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Allergic rhinitis does it have an impact on controller asthma therapy choice Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Usefulness of nasal provocation test in the diagnosis of mite allergic rhinitis: Standard or rapid? Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Persistent allergic sensitization is associated with asthma and rhinitis among adults Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 A phenotype of onset of adult asthma with co-morbid rhinitis Source: Annual Congress 2013 –Asthma Year: 2013 Skin prick test versus specific IgE – A comparative study in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Clinical allergy Year: 2014 Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015